Dermapharm Holding SE

DMPHFOTCHealthcare● Active

$59.00

+$19.44(+49.14%)

Market Cap$2.9B

P/E Ratio—

52W High$59

52W Low$39.56

Avg Volume219.2

Open$59.00

Beta0.88

Net Income Financials Revenue

Dermapharm Holding SE (DMPHF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

DMPHF · net income · updated Jun 9, 2026

Core profitability metrics

DMPHF · net income · margin · TTM · CAGR

Net income was $132.4M for FY2025 (fiscal year ending 2025-12-31), up 16.3% year-over-year. Net profit margin was 11.4%. Based on available data, Dermapharm Holding SE has been profitable since at least 2015.

FY2025 Net Income$132.4M▲ +16.3% YoY

Trailing 12M (TTM)$144.4Mtrailing 4 quarters sum

Net Profit Margin11.4%$132.4M ÷ $1.16B

YoY Change+16.3%—

5-Year CAGR+9.1%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2015

▸ FMP /income-statement · Annual · DMPHF net income history · DMPHF profit margin

Annual net income data

DMPHF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$132.4M▲ +16.3%11.4%$1.16B

FY2024$113.8M▲ +82.4%9.6%$1.18B

FY2023$62.4M▼ 53.5%5.4%$1.15B

FY2022$134.2M▼ 36.0%13.1%$1.02B

FY2021$209.6M▲ +144.2%22.2%$942.9M

Net income vs peers (Healthcare)

DMPHF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Dermapharm Holding SEYOU

DMPHF

$132.4M+16.3%11.4%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Dermapharm Holding SE (DMPHF) reported net income of $132.4M for FY2025 (fiscal year ending 2025-12-31), up 16.3% year-over-year. The net profit margin was 11.4% — meaning the company kept $0.11 of every dollar of revenue as profit.

Based on available data, Dermapharm Holding SE has been profitable since at least 2015. Net income reached a peak of $209.6M in FY2021. Data available for 12 fiscal years.

Dermapharm Holding SE's net profit margin was 11.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Dermapharm Holding SE net worth" — the company's market capitalization is a separate figure from DMPHF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

DMPHF net income · 5 questions

Dermapharm Holding SE is profitable. The company reported net income of $132.4M for FY2025, a net profit margin of 11.4%. Net income was up 16.3% year-over-year. Based on available data, Dermapharm Holding SE has been profitable since at least 2015.

is DMPHF profitabledoes DMPHF make a profitDMPHF profitabilityDMPHF profitable company

▸ Source: FMP /income-statement · GAAP · Dermapharm Holding SE · Dermapharm Holding SE SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026